Main Menu

ESMO Congress 2022

The European Society for Medical Oncology holds an annual congress where scientists and clinicians share the latest research in basic, translational and clinical cancer research. Some of our scientists attend and present findings regarding their latest research.

Here you will find news stories and blog posts about the research our scientists have presented at the congress over the years.

Blog Caption for: ESMO 2023: Using blood tests to help treat breast cancer more precisely – Professor Nick Turner on his award-winning research

ESMO 2023: Using blood tests to help treat breast cancer more precisely – Professor Nick Turner on his award-winning research

Blog Caption for: ESMO 2022: Cancer researchers rendezvous in Paris

ESMO 2022: Cancer researchers rendezvous in Paris

News Caption for: ESMO Virtual Plenary 2022: Major trial shows targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation

ESMO Virtual Plenary 2022: Major trial shows targeted drug improves survival in early-stage breast cancer with inherited BRCA1...

News Caption for: ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers

ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers

News Caption for: ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer

ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer

News Caption for: ESMO 2020: Research breakthrough offers new hope for high risk patients with HR+ breast cancer

ESMO 2020: Research breakthrough offers new hope for high risk patients with HR+ breast cancer

News Caption for: ESMO 2020: Breast cancer drug set to transform prostate cancer treatment

ESMO 2020: Breast cancer drug set to transform prostate cancer treatment

News Caption for: ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer

ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer